Prognostic factors and Outcomes of COVID-19 cases in Ethiopia; Multi sector cohort study protocol. BMC Infectious Disease
Saro Abdella, Masresha Tessema, Geremew Tasew, Atkure Defar, Asefa Deressa, Feyisa Regasa, Frehiwot Teka, Eyasu Tigabu, Dereje Nigussie, Tefera Belachew, Million Molla, Amare Deribew, Workeabeba Abebe, Tegbar Yigzaw, Tsinuel Nigatu, Getnet Mitike, Tewodros Haile, Haftom Taame, Muhammed Ahmed, Frehiwot Nigatu, Tola Tolesa, Eskinder Wolka, Wondwossen Amogne, Arnaud Laillou, Misker Amare, Yaregal Fufa, Alemayehu Argaw, Woldesenbet Waganew, Akilili Azazh, Aschalew Worku, Berhane Redae, Menbeu Sultan, Miraf Walelegn, Muluwork Tefera, Sisay Yifru, Rahel Argaw, Natinael Brehau, Sisay Teklu, Getachew Demoz, Yakob Seman, Mihretab Salasibew, Eshetu Ejeta, Susan J. Whiting, Dawit Wolday, Getachew Tollera, Ebba Abate & Dereje Duguma
Date:
2021-09-16
Abstract:
The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) and became pandemic after emerging in Wuhan, China, in December 2019. Several studies have been conducted to understand the key features of COVID-19 and its public health impact. However, the prognostic factors of COVID-19 are not well studied in the African setting. In this study, we aim to determine the epidemiological and clinical features of COVID-19 cases, immunological and virological courses, interaction with nutritional status, and response to treatment for COVID-19 patients in Ethiopia.
Show full item record